See Explanation of Responses of Progenics Pharmaceuticals Inc (NASDAQ:PGNX), Lte Partners, Llc, buys 21,480 shares worth $106,096

According to Progenics Pharmaceuticals Inc's most recent Form 4 filing with the SEC dated Sep 09 06:14 PM, company See Explanation of Responses, Lte Partners, Llc disclosed buying 21,480 shares at a cost of $4.94. At the time of this transaction (Sep 09), this trade was worth $106,096 in total. As of Sep 09, Lte Partners, Llc now owns 1,950,000 shares in total worth about $9,769,500.0.

For the last few recent trades made by Progenics Pharmaceuticals Inc (NASDAQ:PGNX) See Explanation of Responses, Lte Partners, Llc, we have the following information:

  1. SEC Form 4 filing: Sep 05: Bought 43,520 shares at the rate of $4.62 per share. Total worth of this trade was $201,097. Total number of shares owned as of Sep 05 were 1,928,520
Posted by on Monday September 09 2019, 6:48 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments closed, Trackbacks open. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in